Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
N-Benzylpalmitamide
Cat. No.:
OB0225LY-0438
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
N-Benzylpalmitamide is a fatty acid amide derivative that is biologically active and has a structure that allows it to exhibit good solubility in a wide range of biological environments.
Synonym:
Macamide 1; N-Benzylhexadecanamide; 74058-71-2; Hexadecanamide, N-benzyl-; N-(Phenylmethyl)-hexadecanamide; Hexadecanamide, N-(phenylmethyl)-
CAS No.:
74058-71-2
Compound CID:
11198769
Formula:
C23H39NO
Formula Weight:
345.56
Specification
Relative Density:
0.919 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
N-Benzylpalmitamide can be used to study lipid metabolism or play an important role in cell signaling.
Library Information
Targets:
Metabolic enzymes
Receptors:
FAAH
Pathways:
Neuronal signaling; Autophagy; Metabolism
Plate Number:
AOCL-6
Plate Location:
f5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM Water
Solubility:
Slightly soluble in DSMO.
